TW201602260A - Ion complex material having function for preventing adherence to biological material - Google Patents

Ion complex material having function for preventing adherence to biological material Download PDF

Info

Publication number
TW201602260A
TW201602260A TW104106778A TW104106778A TW201602260A TW 201602260 A TW201602260 A TW 201602260A TW 104106778 A TW104106778 A TW 104106778A TW 104106778 A TW104106778 A TW 104106778A TW 201602260 A TW201602260 A TW 201602260A
Authority
TW
Taiwan
Prior art keywords
coating film
formula
copolymer
hydrogen atom
cells
Prior art date
Application number
TW104106778A
Other languages
Chinese (zh)
Inventor
Yoshiomi Hiroi
Takahiro Kishioka
Taito Nishino
Ayako Otani
Makoto Gemmei
Original Assignee
Nissan Chemical Ind Ltd
Nat Univ Corp Univ Toyama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd, Nat Univ Corp Univ Toyama filed Critical Nissan Chemical Ind Ltd
Publication of TW201602260A publication Critical patent/TW201602260A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04Homopolymers or copolymers of esters
    • C09D133/14Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/38Esters containing sulfur
    • C08F220/382Esters containing sulfur and containing oxygen, e.g. 2-sulfoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D141/00Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur; Coating compositions based on derivatives of such polymers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D201/00Coating compositions based on unspecified macromolecular compounds
    • C09D201/02Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D201/00Coating compositions based on unspecified macromolecular compounds
    • C09D201/02Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C09D201/025Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0238General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52Amides or imides
    • C08F220/54Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide

Abstract

In the present invention, a coating film is formed by a coating-film forming composition being contacted with a base and subsequently being dried. The coating-film forming composition contains a solvent and a copolymer that includes a repeat unit containing an organic group expressed by formula (a) and a repeat unit containing an organic group expressed by formula (b) (in the formula, Ua1 represents a hydrogen atom or an alkali metal atom, and Ub1 and Ub2 each independently represent a hydrogen atom, or a linear or branched alkyl group having 1-5 carbon atoms).

Description

具有活體物質的附著抑制能之離子複合材料 Ion composite material with adhesion inhibiting energy of living substance

本發明係關於具有活體物質的附著抑制能之離子複合材料及使用該離子複合材料之塗膜。 The present invention relates to an ion composite material having an adhesion inhibiting property of a living substance and a coating film using the ion composite material.

為了對人工透析器、人工臟器、醫療器具等醫療用器具、器材等之活體物質附著抑制,已提案有各種各樣具有活體物質的附著抑制能之塗覆材料。 In order to suppress the adhesion of living substances such as medical instruments and equipment such as artificial dialyzers, artificial organs, and medical instruments, various coating materials having adhesion inhibiting properties of living substances have been proposed.

在該等之中,有諸如藉由塗覆在側鏈具乙二醇鏈之聚合物而阻礙活體物質的附著之材料,舉例而言,在專利文獻1中,係記載有將丙烯酸2-甲氧基乙酯的共聚物塗覆於血液過濾器或人工透析過濾器等不織布之例。又,在非專利文獻1中,係記載有對使用為人工透析膜的基體之聚碸(PS)或聚醚碸(PES)等調配聚乙烯吡咯啶酮(PVP)並施行親水性處理。然而,此等材料係由於親水性等效果而具有所期待之活體物質的附著抑制能,另一方面,其抑制對於聚合物本身的水之溶解性並提高對醇或有機溶媒之溶解性,因而利用除菌用的乙醇等之洗淨、高黏度的活體物質等所引起之對塗膜的剪切應力(剪斷應 力)、長時間的使用等係成為原因而確認有塗膜本身的溶出,其溶出物所引起之過敏等係進而造成疑慮。 Among these, there is a material which inhibits adhesion of a living substance by, for example, coating a polymer having an ethylene glycol chain in a side chain. For example, in Patent Document 1, a 2-ethyl acrylate is described. The copolymer of oxyethyl ester is applied to a nonwoven fabric such as a blood filter or an artificial dialysis filter. Further, in Non-Patent Document 1, a polyvinylpyrrolidone (PVP) is prepared by a polypyrene (PS) or a polyether oxime (PES) using a substrate which is a manual dialysis membrane, and is subjected to a hydrophilic treatment. However, these materials have the desired adhesion inhibiting ability of the living substance due to effects such as hydrophilicity, and on the other hand, they inhibit the solubility of water in the polymer itself and improve the solubility to the alcohol or the organic solvent. Shear stress on the coating film caused by washing, high viscosity, and other living substances such as ethanol for sterilization (cutting The reason for the long-term use and the like is that the dissolution of the coating film itself is confirmed, and the allergies caused by the eluted matter are caused to cause further concern.

在另一方面,已知於表面具有在側鏈包含陽離子、陰離子的高分子材料之材料係因其靜電平衡,該表面係保持於電中性而有防止活體物質(蛋白質、細胞等)的吸附之作用。此外,亦已提案有使用該等機能之塗覆材料,關於對玻璃或聚合物基板等之固著/固定化方法,亦已提出各種各樣的報告。 On the other hand, it is known that a material having a polymer material containing a cation or an anion in a side chain is electrostatically balanced, and the surface is maintained in electrical neutrality to prevent adsorption of a living substance (protein, cell, etc.). The role. In addition, coating materials using such functions have also been proposed, and various reports have been made regarding fixing/fixing methods for glass or polymer substrates and the like.

舉例而言,在專利文獻2中,已揭示具有兩性離子部及具電荷的固著部之細菌等的附著防止共聚物作為牙齒保健產品。 For example, Patent Document 2 discloses an adhesion preventing copolymer having a zwitterionic portion and a stagnation portion having a charge as a dental care product.

舉例而言,在專利文獻3中,已揭示為了表面上之非特異性蛋白質附著防止,係使用包含負性帶電的重複單元、正性帶電的重複單元之共聚物。 For example, in Patent Document 3, it has been disclosed that a copolymer comprising a negatively charged repeating unit or a positively charged repeating unit is used for the prevention of non-specific protein adhesion on the surface.

舉例而言,在非專利文獻2中,已揭示含有具有特定的正電荷及負電荷的單體、以及交聯劑之活體物質非附著性水凝膠。 For example, Non-Patent Document 2 discloses a living substance non-adhesive hydrogel containing a monomer having a specific positive and negative charge and a crosslinking agent.

[先前技術文獻] [Previous Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]日本專利特開2001-323030號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2001-323030

[專利文獻2]US2012/0128600A1 [Patent Document 2] US2012/0128600A1

[專利文獻3]日本專利特表2010-500456號公報 [Patent Document 3] Japanese Patent Special Publication 2010-500456

[非專利文獻] [Non-patent literature]

[非專利文獻1]人工臟器,39卷,1號,pp.77 (2010) [Non-Patent Document 1] Artificial Organs, Vol. 39, No. 1, pp. 77 (2010)

[非專利文獻2]J. Phys. Chem. B2012, 116, pp.14346-14352 [Non-Patent Document 2] J. Phys. Chem. B2012, 116, pp. 14346-14352

特定而言,本案發明係提供僅藉由乾燥步驟便可容易地形成之具有活體物質的附著抑制能之塗膜。 In particular, the present invention provides a coating film having an adhesion inhibiting ability of a living substance which can be easily formed only by a drying step.

即,本發明係如下。 That is, the present invention is as follows.

[1]一種塗膜,其係使包含共聚物及溶媒之塗膜形成用組成物接觸至基體後,予以乾燥而形成,該共聚物包含:含下述(式a)所示之1價有機基的重複單元、及含下述(式b)所示之1價有機基的重複單元; (式中,Ua1表示氫原子或鹼金屬原子,Ub1及Ub2各自獨 立地表示氫原子或碳原子數1~5之直鏈或分枝烷基)。 [1] A coating film which is formed by contacting a composition for forming a coating film comprising a copolymer and a solvent, and drying the composition, the copolymer comprising: the monovalent organic group represented by the following formula (a) a repeating unit of a group; and a repeating unit comprising a monovalent organic group represented by the following (formula b); (In the formula, U a1 represents a hydrogen atom or an alkali metal atom, and U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms).

[2]如[1]所記載之塗膜,其中,上述基體係選自玻璃、含有金屬的化合物或含有半金屬的化合物、或樹脂。 [2] The coating film according to [1], wherein the base system is selected from the group consisting of glass, a metal-containing compound, or a semimetal-containing compound, or a resin.

[3]如[1]或[2]所記載之塗膜,其係具有活體物質的附著抑制能。 [3] The coating film according to [1] or [2], which has an adhesion inhibiting ability of a living substance.

[4]如[1]至[3]中任一項所記載之塗膜,其中,上述共聚物包含下述(式a-1)及(式b-1)之重複單元; (式中,Ta、Tb、Ub1及Ub2各自獨立地表示氫原子或碳原子數1~5之直鏈或分枝烷基,Ua1表示氫原子或鹼金屬原子,Qa及Qb各自獨立地表示單鍵、酯鍵(-C(=O)-O-或 -O-C(=O)-)或醯胺鍵(-NHC(=O)-或-C(=O)NH-),Ra及Rb各自獨立地表示單鍵或可經鹵素原子取代之碳原子數1~5之直鏈或分枝伸烷基)。 [4] The coating film according to any one of [1] to [3] wherein the copolymer comprises the following repeating units of (formula a-1) and (formula b-1); (wherein, T a , T b , U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, and U a1 represents a hydrogen atom or an alkali metal atom, Q a and Q b each independently represents a single bond, an ester bond (-C(=O)-O- or -OC(=O)-) or a guanamine bond (-NHC(=O)- or -C(=O)NH -), R a and R b each independently represent a single bond or a straight or branched alkyl group having 1 to 5 carbon atoms which may be substituted by a halogen atom.

本案發明之塗膜可藉由將包含:含(式a)所示之陰離子、(式b)所示之陽離子的共聚物之塗膜形成用組成物接觸至基體後,歷經乾燥步驟而形成。本案之塗膜係藉由使(式a)所示之陰離子、(式b)所示之陽離子形成離子鍵(離子複合物),而可在無須選擇玻璃、含有金屬的化合物或含有半金屬的化合物、或樹脂(合成樹脂及天然樹脂)等基體的種類之情形下進行固著,此外,在固著後係成為對水系溶媒(水、磷酸緩衝液(PBS)、乙醇、異丙醇等)之耐久性優異的塗膜。 The coating film of the present invention can be formed by subjecting a coating film-forming composition containing a copolymer having an anion represented by the formula (a) and a cation represented by the formula (b) to a substrate, followed by a drying step. The coating film of the present invention can form an ionic bond (ion complex) by using an anion represented by (formula a) and a cation represented by (formula b), without selecting a glass, a metal-containing compound or a semimetal-containing compound. Fixing in the case of a compound such as a compound or a resin (synthetic resin or natural resin), and fixing to a water-based solvent (water, phosphate buffer (PBS), ethanol, isopropyl alcohol, etc.) after fixation A coating film excellent in durability.

本案之塗膜係使包含共聚物及溶媒之塗膜形成用組成物接觸至基體後,予以乾燥而形成之塗膜,該共聚物包含:含下述(式a)所示之1價有機基的重複單元、及含下述(式b)所示之1價有機基的重複單元; (式中,Ua1表示氫原子或鹼金屬原子,Ub1及Ub2各自獨立地表示氫原子或碳原子數1~5之直鏈或分枝烷基)。乾燥時的溫度較理想係於大氣下或真空下在溫度-200℃~200℃之範圍中施行。 The coating film of the present invention is a coating film obtained by bringing a composition for forming a coating film comprising a copolymer and a solvent into contact with a substrate and drying the composition, and the copolymer comprises: a monovalent organic group represented by the following formula (a) a repeating unit, and a repeating unit comprising a monovalent organic group represented by the following formula (formula b); (In the formula, U a1 represents a hydrogen atom or an alkali metal atom, and U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms). The temperature at the time of drying is preferably carried out under the atmosphere or under vacuum at a temperature ranging from -200 ° C to 200 ° C.

乾燥係指去除上述塗膜形成用組成物中之溶媒。 Drying refers to the removal of the solvent in the composition for forming a coating film.

上述共聚物只要是包含:含上述(式a)所示之有機基的重複單元、及含上述(式b)所示之有機基的重複單元之共聚物,則無特別限制。該聚合物較理想係使含上述(式a)所示之有機基的單體、與含上述(式b)所示之有機基的單體進行自由基聚合而得者,但亦可使用進行聚縮合、加成聚合反應而成者。作為共聚物之例,可列舉使烯烴進行反應而成之乙烯系聚合物、聚醯胺、聚酯、聚碳酸酯、聚胺酯等,而在此等之中,特別理想係使烯烴進行反應而成之乙烯系聚合物或使(甲基)丙烯酸酯化合物聚合而成之(甲基)丙烯酸系聚合物。 The copolymer is not particularly limited as long as it is a copolymer comprising a repeating unit containing the organic group represented by the above formula (a) and a repeating unit containing the organic group represented by the above formula (b). The polymer is preferably obtained by radically polymerizing a monomer containing the organic group represented by the above formula (a) and a monomer having the organic group represented by the above formula (b), but may be used. Polycondensation, addition polymerization reaction. Examples of the copolymer include an ethylene-based polymer obtained by reacting an olefin, a polyamide, a polyester, a polycarbonate, a polyurethane, and the like. Among them, it is particularly preferable to react an olefin. A vinyl polymer or a (meth)acrylic polymer obtained by polymerizing a (meth) acrylate compound.

另外,本案中,(甲基)丙烯酸酯化合物係指丙烯酸酯化合物及甲基丙烯酸酯化合物兩者。舉例而言,(甲基)丙烯酸係指丙烯酸及甲基丙烯酸。 Further, in the present invention, the (meth) acrylate compound means both an acrylate compound and a methacrylate compound. For example, (meth)acrylic refers to acrylic acid and methacrylic acid.

Ua1係表示氫原子或鹼金屬原子(鋰、鈉、 鉀、銣、銫、鍅)。此等原子成為1價陽離子,與磺酸基之1個氧原子(1價陰離子)形成離子鍵。而在此等之中,特別理想係氫原子、鈉或鉀。 U a1 represents a hydrogen atom or an alkali metal atom (lithium, sodium, potassium, rubidium, cesium, cesium). These atoms form a monovalent cation and form an ionic bond with one oxygen atom (monovalent anion) of the sulfonic acid group. Among these, a hydrogen atom, sodium or potassium is particularly preferable.

作為碳原子數1~5之直鏈或分枝烷基,可列舉例如甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、正戊基、1-甲基丁基、2-甲基丁基、3-甲基丁基、1,1-二甲基丙基、1,2-二甲基丙基、2,2-二甲基丙基或1-乙基丙基。 Examples of the linear or branched alkyl group having 1 to 5 carbon atoms include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a second butyl group, and a t-butyl group. , n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2- Dimethylpropyl or 1-ethylpropyl.

作為Ub1及Ub2,較佳係選自氫原子、甲基或乙基之組合,但特定而言,更佳係兩者皆為甲基。 As U b1 and U b2 , a combination of a hydrogen atom, a methyl group or an ethyl group is preferred, but in particular, it is more preferred that both are methyl groups.

作為本案之塗膜形成用組成物中所包含之溶媒,可列舉水、磷酸緩衝液(PBS)、醇。作為醇,可列舉碳數2~6之醇、例如乙醇、丙醇、異丙醇、1-丁醇、2-丁醇、異丁醇、第三丁醇、1-戊醇、2-戊醇、3-戊醇、1-庚醇、2-庚醇、第三戊醇、2,2-二甲基-1-丙醇(新戊醇)、2-甲基-1-丙醇、2-甲基-1-丁醇、2-甲基-2-丁醇(第三戊醇)、3-甲基-1-丁醇、3-甲基-3-戊醇、環戊醇、1-己醇、2-己醇、3-己醇、2,3-二甲基-2-丁醇、3,3-二甲基-1-丁醇、3,3-二甲基-2-丁醇、2-二乙基-1-丁醇、2-甲基-1-戊醇、2-甲基-2-戊醇、2-甲基-3-戊醇、3-甲基-1-戊醇、3-甲基-2-戊醇、3-甲基-3-戊醇、4-甲基-1-戊醇、4-甲基-2-戊醇、4-甲基-3-戊醇、1-丁氧基-2-丙醇及環己醇,可單獨使用或使用該等之組合的混合溶媒,但從共聚物的溶解之觀點而言,可單獨使用水、PBS、乙醇、異丙 醇或使用該等之組合的混合溶媒。 Examples of the solvent contained in the composition for forming a coating film of the present invention include water, a phosphate buffer solution (PBS), and an alcohol. Examples of the alcohol include alcohols having 2 to 6 carbon atoms, such as ethanol, propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, tert-butanol, 1-pentanol, and 2-pentane. Alcohol, 3-pentanol, 1-heptanol, 2-heptanol, third pentanol, 2,2-dimethyl-1-propanol (neopentyl alcohol), 2-methyl-1-propanol, 2-methyl-1-butanol, 2-methyl-2-butanol (third pentanol), 3-methyl-1-butanol, 3-methyl-3-pentanol, cyclopentanol, 1-hexanol, 2-hexanol, 3-hexanol, 2,3-dimethyl-2-butanol, 3,3-dimethyl-1-butanol, 3,3-dimethyl-2 -butanol, 2-diethyl-1-butanol, 2-methyl-1-pentanol, 2-methyl-2-pentanol, 2-methyl-3-pentanol, 3-methyl- 1-pentanol, 3-methyl-2-pentanol, 3-methyl-3-pentanol, 4-methyl-1-pentanol, 4-methyl-2-pentanol, 4-methyl- 3-pentanol, 1-butoxy-2-propanol and cyclohexanol may be used singly or as a mixed solvent of the combination, but from the viewpoint of dissolution of the copolymer, water or PBS may be used alone. , ethanol, isopropyl Alcohol or a mixed solvent using a combination of these.

上述共聚物中之含(式a)所示之有機基的重複單元之比例為5莫耳%~80莫耳%。較佳為6莫耳%~75莫耳%,更佳為7莫耳%~50莫耳%,再佳為8莫耳%~40莫耳%。另外,涉及本發明之共聚物亦可包含2種以上的含(式a)所示之有機基的重複單元。 The ratio of the repeating unit containing the organic group represented by (formula a) in the above copolymer is from 5 mol% to 80 mol%. It is preferably from 6 mol% to 75 mol%, more preferably from 7 mol% to 50 mol%, and even more preferably from 8 mol% to 40 mol%. Further, the copolymer according to the present invention may contain two or more kinds of repeating units containing an organic group represented by the formula (a).

在上述組成物之溶媒為水之情況,上述共聚物中之含(式a)所示之有機基的重複單元之比例較佳為7莫耳%~50莫耳%,更佳為8莫耳%~40莫耳%。 In the case where the solvent of the above composition is water, the proportion of the repeating unit containing the organic group represented by (formula a) in the above copolymer is preferably from 7 mol% to 50 mol%, more preferably 8 mol%. %~40% by mole.

在上述組成物之溶媒為PBS之情況,上述共聚物中之含(式a)所示之有機基的重複單元之比例較佳為5莫耳%~80莫耳%,更佳為6莫耳%~75莫耳%,再佳為7莫耳%~70莫耳%,最佳為8莫耳%~65莫耳%。 In the case where the solvent of the above composition is PBS, the ratio of the repeating unit containing the organic group represented by the formula (a) in the copolymer is preferably from 5 mol% to 80 mol%, more preferably 6 mol%. %~75% by mole, and then preferably 7% by mole to 70% by mole, and most preferably 8% by mole to 655% by mole.

上述共聚物中之含(式b)所示之有機基的重複單元之比例可為對所有共聚物減去上述(式a)而成之所有殘餘部分,亦可為減去上述(式a)及下述所記之第3成分的合計比例而成之殘餘部分。另外,涉及本發明之共聚物亦可包含2種以上的含(式b)所示之有機基的重複單元。 The ratio of the repeating unit containing the organic group represented by (formula b) in the above copolymer may be any residue obtained by subtracting the above (formula a) from all the copolymers, or may be subtracted from the above (formula a) And the remainder of the total ratio of the third component described below. Further, the copolymer according to the present invention may further contain two or more kinds of repeating units containing an organic group represented by (formula b).

作為塗膜形成用組成物中之固形份的濃度,為了使塗膜均勻地形成,較理想係0.01~50質量%。 The concentration of the solid content in the composition for forming a coating film is preferably 0.01 to 50% by mass in order to uniformly form the coating film.

塗膜形成用組成物中之固形份係指從組成物中去除溶媒等液體成分而成者。 The solid content in the composition for forming a coating film means that the liquid component such as a solvent is removed from the composition.

再者,本案之塗膜形成用組成物除了上述共 聚物及溶媒以外,亦可視需要在不會損及所得塗膜的性能之範圍中添加其他物質。作為其他物質,可列舉防腐劑、界面活性劑、提高與基材間的密著性之底塗劑等。 Furthermore, the composition for forming a coating film of the present invention is in addition to the above In addition to the polymer and the solvent, other substances may be added as needed within a range that does not impair the performance of the obtained coating film. Examples of the other substance include a preservative, a surfactant, and a primer for improving the adhesion to the substrate.

使上述步驟中所得之塗膜形成用組成物接觸至基體而形成塗膜。 The coating film-forming composition obtained in the above step is brought into contact with a substrate to form a coating film.

用以形成本案塗膜之基體較佳係使用玻璃、含有金屬的化合物或含有半金屬的化合物、活性碳、或樹脂。 The substrate for forming the coating film of the present invention is preferably glass, a metal-containing compound or a semimetal-containing compound, activated carbon, or a resin.

含有金屬的化合物或含有半金屬的化合物可列舉例如基本成分為金屬氧化物並屬於藉由在高溫的熱處理燒固而成之燒結體之陶瓷、諸如矽之半導體、金屬氧化物或半金屬氧化物(矽氧化物、氧化鋁等)、金屬碳化物或半金屬碳化物、金屬氮化物或半金屬氮化物(矽氮化物等)、金屬硼化物或半金屬硼化物等無機化合物之成形體等無機固體材料、鋁、鎳鈦、不鏽鋼(SUS304、SUS316、SUS316L等)。 The metal-containing compound or the semimetal-containing compound may, for example, be a ceramic whose basic component is a metal oxide and which is sintered by heat treatment at a high temperature, a semiconductor such as ruthenium, a metal oxide or a semi-metal oxide. Inorganic (such as niobium oxide, aluminum oxide, etc.), metal carbide or semi-metal carbide, metal nitride or semi-metal nitride (such as niobium nitride), inorganic compound such as metal boride or semi-metal boride Solid material, aluminum, nickel titanium, stainless steel (SUS304, SUS316, SUS316L, etc.).

作為樹脂,天然樹脂或合成樹脂皆可,作為天然樹脂,較佳係使用纖維素、三醋酸纖維素(CTA)、將硫酸葡聚糖固定化而成之纖維素等,作為合成樹脂,較佳係使用聚丙烯腈(PAN)、聚酯系聚合物合金(PEPA)、聚苯乙烯(PS)、聚碸(PSF)、聚對苯二甲酸乙二酯(PET)、聚甲基丙烯酸甲酯(PMMA)、聚乙烯醇(PVA)、聚胺酯(PU)、乙烯-乙烯醇共聚物(EVAL)、聚乙烯(PE)、聚酯(PE)、聚丙烯 (PP)、聚偏二氟乙烯(PVDF)、各種離子交換樹脂或聚醚碸(PES)等。由於本案塗膜可利用低溫乾燥而形成,故亦可應用於耐熱性低的樹脂等。 As the resin, a natural resin or a synthetic resin may be used. As the natural resin, cellulose, cellulose triacetate (CTA), cellulose obtained by immobilizing dextran sulfate, and the like are preferably used as the synthetic resin. Polyacrylonitrile (PAN), polyester polymer alloy (PEPA), polystyrene (PS), polyfluorene (PSF), polyethylene terephthalate (PET), polymethyl methacrylate (PMMA), polyvinyl alcohol (PVA), polyurethane (PU), ethylene-vinyl alcohol copolymer (EVAL), polyethylene (PE), polyester (PE), polypropylene (PP), polyvinylidene fluoride (PVDF), various ion exchange resins or polyether oxime (PES). Since the coating film of the present invention can be formed by drying at a low temperature, it can also be applied to a resin having low heat resistance.

為了形成本案塗膜,係使塗膜形成用組成物接觸至基體的表面之至少一部分。作為接觸方法,並無特別限制,可使用通常的旋轉塗佈、浸漬塗佈、溶媒澆鑄法等公知的塗佈法。 In order to form the coating film of the present invention, the coating film forming composition is brought into contact with at least a part of the surface of the substrate. The contact method is not particularly limited, and a known coating method such as usual spin coating, dip coating, or solvent casting method can be used.

本案塗膜之乾燥溫度並無特別限定,但通常於大氣下或真空下,在溫度-200℃~200℃之範圍內施行,藉此使本案共聚物之(式a)及(式b)彼此形成離子鍵而完全地固著至基體。 The drying temperature of the coating film of the present invention is not particularly limited, but is usually carried out in the range of -200 ° C to 200 ° C under atmospheric pressure or under vacuum, whereby the copolymers of the present invention (formula a) and (formula b) are mutually An ionic bond is formed and is completely fixed to the substrate.

舉例而言,雖然藉由在室溫(10℃~35℃,例如25℃)之乾燥亦可形成,但為了使塗膜更迅速地形成,亦可於例如40℃~50℃進行乾燥。又,亦可使用利用冷凍乾燥法之在極低溫~低溫(-200℃~-30℃前後)之乾燥步驟。冷凍乾燥係稱為真空凍結乾燥,其係通常藉由將欲乾燥之物以冷媒進行冷卻,於真空狀態將溶媒昇華而予以去除之方法。冷凍乾燥中所使用之一般性冷媒可列舉乾冰及甲醇之混合媒劑(-78℃)、液態氮(-196℃)等。 For example, although it can be formed by drying at room temperature (10 ° C to 35 ° C, for example, 25 ° C), in order to form the coating film more rapidly, it can be dried, for example, at 40 ° C to 50 ° C. Further, a drying step of a very low temperature to a low temperature (before and after -200 ° C to -30 ° C) by a freeze drying method can also be used. Freeze-drying is a method of vacuum freeze-drying, which is usually carried out by sublimating a solvent in a vacuum state by cooling the object to be dried with a refrigerant. Examples of the general refrigerant used in the freeze-drying include a mixed medium of dry ice and methanol (-78 ° C), liquid nitrogen (-196 ° C), and the like.

若乾燥溫度為-200℃以下,則必須使用非一般性冷媒,欠缺泛用性,為了溶媒昇華,在乾燥時需要長時間,效率較差。若乾燥溫度為200℃以上,則會過度進行塗膜表面的離子鍵反應而使該表面失去親水性,無法發 揮活體物質附著抑制能。更佳的乾燥溫度為10℃~180℃,再更佳的乾燥溫度為25℃~150℃。 When the drying temperature is -200 ° C or less, it is necessary to use a non-general refrigerant, which lacks versatility, and in order to sublimate the solvent, it takes a long time to dry and is inefficient. If the drying temperature is 200 ° C or more, the ionic bond reaction on the surface of the coating film is excessively performed, and the surface loses hydrophilicity and cannot be emitted. The body substance adhesion inhibition energy is stimulated. A more preferred drying temperature is from 10 ° C to 180 ° C, and a more preferred drying temperature is from 25 ° C to 150 ° C.

乾燥後,為了清除殘存於該塗膜上之雜質、未反應單體等,較理想係以水、PBS等利用流水洗淨或超音波洗淨等進行洗淨。上述水或PBS亦可例如為在40℃~95℃之範圍中進行加溫而成者。固著後,即便以水、PBS及醇等進行洗淨,塗膜仍不會溶出而依原樣強固地固著於基體。所形成之塗膜即便附著有活體物質,其後利用水洗等便可容易地予以除去,形成有本案塗膜之基體表面係具有附著抑制能。 After drying, in order to remove impurities, unreacted monomers, and the like remaining on the coating film, it is preferred to wash with water, PBS, or the like by running water or ultrasonic cleaning. The water or PBS may be, for example, heated in the range of 40 ° C to 95 ° C. After the fixation, even if it is washed with water, PBS, alcohol or the like, the coating film does not elute and is firmly fixed to the substrate as it is. The formed coating film can be easily removed by washing with water or the like even after adhering to the living material, and the surface of the substrate on which the coating film of the present invention is formed has adhesion inhibiting ability.

作為本案塗膜之應用事例,例如有人工透析器的過濾器用塗膜,而本案塗膜對使用於過濾器之合成樹脂(例如PES、PS等)之塗膜固著性、固著後之耐久性亦良好。 As an application example of the coating film of the present invention, for example, there is a coating film for a filter of an artificial dialyzer, and the coating film of the present invention is durable to the coating film of a synthetic resin (for example, PES, PS, etc.) used for the filter, and durable after fixation. Sex is also good.

基體的形態並無特別限制,可列舉基板、纖維、粒子、凝膠形態、多孔質形態等,形狀可為平板,亦可為曲面。 The form of the substrate is not particularly limited, and examples thereof include a substrate, a fiber, a particle, a gel form, and a porous form, and the shape may be a flat plate or a curved surface.

舉例而言,在作成人工透析器的過濾器用塗膜之情況,可將本案塗膜形成組成物通液至以上述素材所作成且設成例如直徑0.1~500μm的中空絲形狀之過濾器的內側,其後歷經乾燥步驟、洗淨步驟(熱水(例如40℃~95℃)洗淨等)而進行製作。 For example, in the case of forming a coating film for a filter of an artificial dialyzer, the coating film forming composition of the present invention can be passed through to the inside of the filter made of the above material and provided, for example, in the shape of a hollow fiber having a diameter of 0.1 to 500 μm. Then, it is produced by a drying step and a washing step (hot water (for example, 40° C. to 95° C.) washing).

視需要,亦有為了滅菌而進行γ射線、環氧乙烷、高壓釜等處理之情況。 If necessary, gamma rays, ethylene oxide, autoclave, etc. may be treated for sterilization.

作為活體物質,可列舉蛋白質、糖、核酸及細胞、或該等之組合。舉例而言,作為蛋白質,可列舉纖維蛋白原、牛血清白蛋白(BSA)、人類白蛋白、各種球蛋白、β-脂蛋白、各種抗體(IgG、IgA、IgM)、過氧化酶、各種補體、各種凝集素、纖維黏連蛋白、溶菌酶、溫韋伯氏因子(von Willebrand’s factor,vWF)、血清γ-球蛋白、胃蛋白酶、卵白白蛋白、胰島素、組蛋白、核糖核酸酶、膠原蛋白、細胞色素c;舉例而言,作為糖,可列舉葡萄糖、半乳糖、甘露糖、果糖、肝素、玻尿酸;舉例而言,作為核酸,可列舉去氧核糖核酸(DNA)、核糖核酸(RNA);舉例而言,作為細胞,可列舉纖維母細胞、骨髓細胞、B淋巴球、T淋巴球、嗜中性球、紅血球、血小板、巨噬細胞、單核球、骨細胞、骨髓細胞、周皮細胞、樹枝狀細胞、角質細胞、脂肪細胞、間葉細胞、上皮細胞、表皮細胞、內皮細胞、血管內皮細胞、肝實質細胞、軟骨細胞、卵丘細胞、神經系統細胞、神經膠細胞、神經元、寡突細胞、小神經膠質、星狀膠細胞、心臟細胞、食道細胞、肌肉細胞(例如平滑肌細胞或骨骼肌細胞)、胰臟β細胞、黑色素細胞、造血前驅細胞、單核細胞、胚性幹細胞(ES細胞)、胚性腫瘤細胞、胚性生殖幹細胞、人工多能性幹細胞(iPS細胞)、神經幹細胞、造血幹細胞、間葉系幹細胞、肝幹細胞、胰幹細胞、肌肉幹細胞、生殖幹細胞、腸幹細胞、癌幹細胞、毛囊幹細胞、及各種細胞株(例如HCT116、Huh7、HEK293(人 類胎兒腎細胞)、HeLa(人類子宮頸癌細胞株)、HepG2(人類肝癌細胞株)、UT7/TPO(人類白血病細胞株)、CHO(中國倉鼠卵巢細胞株)、MDCK、MDBK、BHK、C-33A、HT-29、AE-1、3D9、Ns0/1、Jurkat、NIH3T3、PC12、S2、Sf9、Sf21、High Five、Vero)等,本案塗膜係特別對血小板具有高附著抑制能。又,本案塗膜係對混雜有蛋白質、糖等之血清具有特別高的附著抑制能。 Examples of the living substance include a protein, a sugar, a nucleic acid, and a cell, or a combination thereof. For example, examples of the protein include fibrinogen, bovine serum albumin (BSA), human albumin, various globulins, β-lipoprotein, various antibodies (IgG, IgA, IgM), peroxidase, various complements. , various lectins, fibronectin, lysozyme, von Willebrand's factor (vWF), serum gamma globulin, pepsin, ovalbumin, insulin, histones, ribonuclease, collagen, The cytochrome c; examples of the sugar include glucose, galactose, mannose, fructose, heparin, and hyaluronic acid; and examples of the nucleic acid include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA); For example, as the cells, there may be mentioned fibroblasts, bone marrow cells, B lymphocytes, T lymphocytes, neutrophils, red blood cells, platelets, macrophages, mononuclear cells, bone cells, bone marrow cells, and pericardial cells. , dendritic cells, keratinocytes, adipocytes, mesenchymal cells, epithelial cells, epidermal cells, endothelial cells, vascular endothelial cells, hepatocytes, chondrocytes, cumulus cells Nervous system cells, glial cells, neurons, oligodendrocytes, microglia, astrocytes, heart cells, esophageal cells, muscle cells (such as smooth muscle cells or skeletal muscle cells), pancreatic beta cells, melanocytes, Hematopoietic precursor cells, monocytes, embryonic stem cells (ES cells), embryogenic tumor cells, embryogenic germ cells, artificial pluripotent stem cells (iPS cells), neural stem cells, hematopoietic stem cells, mesenchymal stem cells, hepatic stem cells, Pancreatic stem cells, muscle stem cells, germ stem cells, intestinal stem cells, cancer stem cells, hair follicle stem cells, and various cell lines (eg, HCT116, Huh7, HEK293 (human) Fetal kidney cells), HeLa (human cervical cancer cell line), HepG2 (human liver cancer cell line), UT7/TPO (human leukemia cell line), CHO (Chinese hamster ovary cell line), MDCK, MDBK, BHK, C -33A, HT-29, AE-1, 3D9, Ns0/1, Jurkat, NIH3T3, PC12, S2, Sf9, Sf21, High Five, Vero), etc., in this case, the coating system has high adhesion inhibition ability to platelets. Further, the coating film of the present invention has a particularly high adhesion inhibiting ability to serum mixed with proteins, sugars and the like.

因本案發明之塗膜具有活體物質的附著抑制能,故可適宜地使用為醫療用基材用塗膜。舉例而言,可在白血球除去過濾器、輸血過濾器、病毒除去過濾器、微小凝血塊除去過濾器、血液淨化用模組、人工心臟、人工肺、血液迴路、人工血管、血管分流管、醫療用管件、人工瓣膜、套管、支架、導管、血管內導管、氣球導管、導線、縫合線、留置針、分流器、人工關節、人工臀關節、血袋、血液保存容器、手術用輔助器具、黏連防止膜、創傷被覆材等中適宜地使用。此處,血液淨化用模組係指具有使血液循環至體外,而去除血中的老廢物質或有害物質之機能的模組,可列舉人工腎臟、毒素吸附過濾器或管柱等。 Since the coating film of the present invention has an adhesion inhibiting ability of a living substance, it can be suitably used as a coating film for a medical substrate. For example, a leukocyte removal filter, a blood transfusion filter, a virus removal filter, a microcoagulation removal filter, a blood purification module, an artificial heart, an artificial lung, a blood circuit, an artificial blood vessel, a blood vessel shunt, a medical treatment Tubes, prosthetic valves, cannulas, stents, catheters, intravascular catheters, balloon catheters, wires, sutures, indwelling needles, shunts, artificial joints, artificial hip joints, blood bags, blood storage containers, surgical aids, It is suitably used for the adhesion preventing film, the wound covering material, and the like. Here, the blood purification module refers to a module having a function of circulating blood to the outside of the body to remove old waste materials or harmful substances in the blood, and examples thereof include an artificial kidney, a toxin adsorption filter, and a column.

此外,本案發明之塗膜係有用於作為燒瓶、皿、盤等細胞培養容器、或抑制蛋白質的附著之各種研究用器具之塗膜。 Further, the coating film of the present invention is a coating film for use as a cell culture container such as a flask, a dish, or a tray, or various research instruments for inhibiting adhesion of proteins.

此外,本案發明之塗膜亦有用於作為化妝品用材料、隱形眼鏡保養用品用材料、肌膚保養用纖維加工 劑、生化學研究用診斷藥用材料、臨床診斷法中廣泛使用之用以抑制酵素免疫測定(ELISA)法或乳膠凝集法中之非特異性吸附之阻斷劑、用以使酵素或抗體等蛋白質安定化之安定化劑。 In addition, the coating film of the present invention is also used as a material for cosmetics, a material for contact lens maintenance products, and a fiber for skin care. Agents, diagnostic medicinal materials for biochemical research, and blockers widely used in clinical diagnostic methods to inhibit non-specific adsorption in enzyme immunoassay (ELISA) or latex agglutination, for enzymes or antibodies A stabilizer for protein stabilization.

本案塗膜形成組成物中所包含之共聚物特佳係使用包含下述(式a-1)及(式b-1)之重複單元之共聚物。 The copolymer contained in the coating film-forming composition of the present invention is particularly preferably a copolymer comprising repeating units of the following (formulae-1) and (formula b-1).

式中,Ta、Tb、Ub1及Ub2各自獨立地表示氫原子或碳原子數1~5之直鏈或分枝烷基。Ua1表示氫原子或鹼金屬原子。Qa及Qb各自獨立地表示單鍵、酯鍵(-C(=O)-O-或-O-C(=O)-)或醯胺鍵(-NHC(=O)-或-C(=O)NH-),Ra及Rb各自獨立地表示可經鹵素原子取代之碳原子 數1~5之直鏈或分枝伸烷基。 In the formula, T a , T b , U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms. U a1 represents a hydrogen atom or an alkali metal atom. Q a and Q b each independently represent a single bond, an ester bond (-C(=O)-O- or -OC(=O)-) or a guanamine bond (-NHC(=O)- or -C(= O) NH-), R a and R b each independently represent a straight or branched alkyl group having 1 to 5 carbon atoms which may be substituted by a halogen atom.

作為碳原子數1~5之直鏈或分枝伸烷基,係對應於上述烷基之2價有機基,可列舉例如亞甲基、伸乙基、伸丙基、三亞甲基、四亞甲基、1-甲基伸丙基、2-甲基伸丙基、二甲基伸乙基、乙基伸乙基、五亞甲基、1-甲基-四亞甲基、2-甲基-四亞甲基、1,1-二甲基-三亞甲基、1,2-二甲基-三亞甲基、2,2-二甲基-三亞甲基、1-乙基-三亞甲基等,而特佳係伸乙基、伸丙基或三亞甲基。上述伸乙基、伸丙基或三亞甲基的氫原子係一部分或全部可經鹵素原子取代。 The linear or branched alkyl group having 1 to 5 carbon atoms corresponds to the divalent organic group of the above alkyl group, and examples thereof include a methylene group, an ethylidene group, a propyl group, a trimethylene group, and a tetrazene group. Methyl, 1-methylpropyl, 2-methylpropyl, dimethyl-ethyl, ethylethyl, pentamethylene, 1-methyl-tetramethylene, 2-methyl -tetramethylene, 1,1-dimethyl-trimethylene, 1,2-dimethyl-trimethylene, 2,2-dimethyl-trimethylene, 1-ethyl-trimethylene Etc., and particularly excellent ethyl, propyl or trimethylene. A part or all of the hydrogen atom of the above-mentioned ethyl, propyl or trimethylene group may be substituted with a halogen atom.

鹵素原子可列舉氟原子、氯原子、溴原子、碘原子。 Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.

上述共聚物中所包含之含(式a-1)所示之有機基的重複單元之比例為5莫耳%~80莫耳%。較佳為6莫耳%~75莫耳%,更佳為7莫耳%~50莫耳%,再佳為8莫耳%~40莫耳%。另外,涉及本發明之共聚物亦可包含2種以上的含(式a-1)所示之有機基的重複單元。 The ratio of the repeating unit containing the organic group represented by (formula a-1) contained in the above copolymer is from 5 mol% to 80 mol%. It is preferably from 6 mol% to 75 mol%, more preferably from 7 mol% to 50 mol%, and even more preferably from 8 mol% to 40 mol%. Further, the copolymer according to the present invention may contain two or more kinds of repeating units containing an organic group represented by (formula a-1).

上述共聚物中所包含之含(式b-1)所示之有機基的重複單元之比例可為對所有共聚物減去上述(式a-1)而成之所有殘餘部分,亦可為減去上述(式a-1)及下述所記之第3成分的合計比例而成之殘餘部分。另外,涉及本發明之共聚物亦可包含2種以上的含(式b-1)所示之有機基的重複單元。 The ratio of the repeating unit containing the organic group represented by (Formula b-1) contained in the above copolymer may be any residue obtained by subtracting the above (Formula a-1) from all the copolymers, or may be subtracted The remainder of the above-mentioned (formula a-1) and the total ratio of the third component described below is obtained. Further, the copolymer according to the present invention may contain two or more kinds of repeating units containing an organic group represented by (formula b-1).

用以形成本案塗膜之塗膜形成組成物中所包 含之共聚物較理想係可藉由使下述(式a-1-1)及(式b-1-1)所示之化合物於反應用溶媒中進行反應(聚合)而合成; The copolymer contained in the coating film forming composition for forming the coating film of the present invention is preferably reacted by the following compounds (formulas a-1-1) and (formula b-1-1). The reaction is carried out by polymerization (polymerization) in a solvent;

(式中,Ta、Tb、Ub1及Ub2各自獨立地表示氫原子或碳原子數1~5之直鏈或分枝烷基,Ua1表示氫原子或鹼金屬原子,Qa及Qb各自獨立地表示單鍵、酯鍵(-C(=O)-O-或-O-C(=O)-)或醯胺鍵(-NHC(=O)-或-C(=O)NH-),Ra及Rb各自獨立地表示單鍵或可經鹵素原子取代之碳原子數1~5之直鏈或分枝伸烷基)。 (wherein, T a , T b , U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, and U a1 represents a hydrogen atom or an alkali metal atom, Q a and Q b each independently represents a single bond, an ester bond (-C(=O)-O- or -OC(=O)-) or a guanamine bond (-NHC(=O)- or -C(=O)NH -), R a and R b each independently represent a single bond or a straight or branched alkyl group having 1 to 5 carbon atoms which may be substituted by a halogen atom.

作為上述(式a-1-1)之具體例,可列舉乙烯基磺酸、乙烯基磺酸鈉鹽、乙烯基磺酸鉀鹽、(甲基)丙烯酸2-磺酸基乙酯、(甲基)丙烯酸3-氯-2-磺酸基丙 酯、(甲基)丙烯酸3-磺酸基丙酯、酸性(甲基)丙烯酸磺酸基甲酯、(甲基)丙烯酸3-磺酸基丙酯鈉鹽、(甲基)丙烯酸3-磺酸基丙酯鉀鹽等,而在此之中,較佳係使用乙烯基磺酸、乙烯基磺酸鈉鹽、乙烯基磺酸鉀鹽、(甲基)丙烯酸3-磺酸基丙酯鈉鹽及(甲基)丙烯酸3-磺酸基丙酯鉀鹽,最佳係使用丙烯酸3-磺酸基丙酯鉀鹽。 Specific examples of the above (formula a-1-1) include vinylsulfonic acid, sodium vinylsulfonate, potassium sulfonate, and 2-sulfonic acid ethyl (meth)acrylate. 3-chloro-2-sulfonic acid Ester, 3-sulfonic acid propyl (meth)acrylate, acid sulfonic acid methyl (meth) acrylate, sodium 3-sulfonate propyl (meth) acrylate, 3-sulfonic acid (meth) acrylate An acid propyl ester potassium salt or the like, and among them, vinyl sulfonic acid, sodium vinyl sulfonate, potassium vinyl sulfonate, sodium 3-sulfonate (meth) acrylate is preferably used. The salt and the potassium 3-sulfonate propyl (meth)acrylate are preferably potassium 3-sulfonate acrylate.

乙烯基磺酸、乙烯基磺酸鈉鹽、乙烯基磺酸鉀鹽、(甲基)丙烯酸3-磺酸基丙酯鈉鹽及(甲基)丙烯酸3-磺酸基丙酯鉀鹽的構造式係以下述(式3-1)及(式3-2)表示。 Structure of vinyl sulfonic acid, sodium vinyl sulfonate, potassium vinyl sulfonate, sodium 3-sulfonate (meth) acrylate and potassium 3-sulfonate (meth) acrylate The formula is represented by the following (Formula 3-1) and (Formula 3-2).

作為上述(式b-1-1)之具體例,可列舉(甲基)丙烯酸二甲基胺基乙酯、(甲基)丙烯酸二乙基胺基乙酯、(甲基)丙烯酸二甲基胺基丙酯,而在此之中,較佳係使用甲基丙烯酸二甲基胺基乙酯。 Specific examples of the above (formula b-1-1) include dimethylaminoethyl (meth)acrylate, diethylaminoethyl (meth)acrylate, and dimethyl (meth)acrylate. Aminopropyl ester, and among them, dimethylaminoethyl methacrylate is preferably used.

丙烯酸二甲基胺基乙酯(=丙烯酸2-(二甲基胺基)乙酯)(式3-3)、甲基丙烯酸二甲基胺基乙酯(=甲基丙烯酸2-(二甲基胺基)乙酯)(式3-4)的構造式係以下述(式3-3)及(式3-4)表示。 Dimethylaminoethyl acrylate (= 2-(dimethylamino)ethyl acrylate) (Formula 3-3), dimethylaminoethyl methacrylate (= 2-(dimethyl methacrylate) The structural formula of the formula (Ethylamino)ethyl ester (Formula 3-4) is represented by the following (Formula 3-3) and (Formula 3-4).

再者,本案組成物的共聚物亦可進一步共聚合有任意的第3成分。 Further, the copolymer of the composition of the present invention may be further copolymerized with any third component.

(式a-1-1)所示之化合物對形成上述共聚物之單體全體之比例為5莫耳%~80莫耳%。 The ratio of the compound represented by the formula (a-1-1) to the entire monomer forming the above copolymer is from 5 mol% to 80 mol%.

(式b-1-1)所示之化合物對形成上述共聚物之單體全體之比例可為減去上述(式a-1-1)之比例而成之所有殘餘部分,亦可為減去上述(式a-1-1)及下述所記之第3成分的合計比例而成之殘餘部分。 The ratio of the compound represented by the formula (Formula b-1-1) to the entire monomer forming the above copolymer may be any residue obtained by subtracting the ratio of the above (formula a-1-1), or may be subtracted The remainder of the above (formula a-1-1) and the total ratio of the third component described below.

作為本案共聚物之合成方法,可藉由屬於一般的丙烯酸系聚合物或甲基丙烯酸系聚合物等之合成方法之自由基聚合、陰離子聚合、陽離子聚合等方法進行合成。其形態可為溶液聚合、懸浮聚合、乳化聚合、塊狀聚合等各種方法。 The synthesis method of the copolymer of the present invention can be carried out by a method such as radical polymerization, anionic polymerization or cationic polymerization which is a synthetic method of a general acrylic polymer or a methacrylic polymer. The form may be various methods such as solution polymerization, suspension polymerization, emulsion polymerization, and bulk polymerization.

作為反應用溶媒,可為水、磷酸緩衝液或乙醇等醇、或將此等組合而成之混合溶媒。 The solvent for the reaction may be water, a phosphate buffer or an alcohol such as ethanol, or a mixed solvent obtained by combining these.

再者,反應溶媒亦可為了提升單體及聚合物的溶解性 而進行加溫(例如40℃~100℃)。 Furthermore, the reaction solvent can also improve the solubility of the monomer and the polymer. Heating is performed (for example, 40 ° C ~ 100 ° C).

為了有效率地進行聚合反應,較理想係使用聚合起始劑。作為聚合起始劑之例,可使用2,2’-偶氮雙(異丁腈)、2,2’-偶氮雙(2-甲基丁腈)、2,2’-偶氮雙(2,4-二甲基戊腈)、4,4’-偶氮雙(4-氰基戊酸)、2,2’-偶氮雙(4-甲氧基-2,4-二甲基戊腈)、1,1’-偶氮雙(環己烷-1-甲腈)、1-[(1-氰基-1-甲基乙基)偶氮]甲醯胺、2,2’-偶氮雙[2-(2-咪唑啉-2-基)丙烷]二鹽酸鹽(和光純藥工業(股)製品名;VA-044)、2,2’-偶氮雙[2-(2-咪唑啶-2-基)丙烷]二硫酸鹽二水合物(和光純藥工業(股)製品名;VA-046B)、2,2’-偶氮雙[2-(2-咪唑啉-2-基)丙烷](和光純藥工業(股)製品名;VA-061)、2,2’-偶氮雙(2-甲基丙脒)二鹽酸鹽(和光純藥工業(股)製品名;V-50)、2,2’-偶氮雙[2-甲基-N-(2-羥基乙基)丙醯胺)(和光純藥公司製品名;VA-086)、過氧化苯甲醯(BPO)、2,2’-偶氮雙(N-(2-羧基乙基)-2-甲基丙脒)n-水合物(和光純藥工業(股)製品名;VA-057)、4,4’-偶氮雙(4-氰基戊酸)(和光純藥公司製品名;VA-501)、過氧二硫酸或第三丁基氫過氧化物等,而在此之中,考慮到離子平衡、對水的溶解性,較理想係使用2,2’-偶氮雙[2-甲基-N-(2-羥基乙基)丙醯胺)、2,2’-偶氮雙(N-(2-羧基乙基)-2-甲基丙脒)n-水合物、4,4’-偶氮雙(4-氰基戊酸)、2,2’-偶氮雙[2-(2-咪唑啶-2-基)丙烷)二鹽酸鹽、2,2’-偶氮雙[2-(2-咪唑啶-2- 基)丙烷]二硫酸鹽二水合物、2,2’-偶氮雙[2-(2-咪唑啶-2-基)丙烷]、2,2’-偶氮雙(2-甲基丙脒)二鹽酸鹽或過氧二硫酸中之任一者。 In order to carry out the polymerization efficiently, it is preferred to use a polymerization initiator. As an example of the polymerization initiator, 2,2'-azobis(isobutyronitrile), 2,2'-azobis(2-methylbutyronitrile), 2,2'-azobis ( 2,4-Dimethylvaleronitrile), 4,4'-azobis(4-cyanovaleric acid), 2,2'-azobis(4-methoxy-2,4-dimethyl Valeronitrile), 1,1'-azobis(cyclohexane-1-carbonitrile), 1-[(1-cyano-1-methylethyl)azo]carbamamine, 2,2' -Azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride (Wako Pure Chemical Industries, Ltd. product name; VA-044), 2,2'-azobis[2- (2-imidazolidin-2-yl)propane]disulfate dihydrate (Wako Pure Chemical Industries, Ltd. product name; VA-046B), 2,2'-azobis[2-(2-imidazoline) -2-yl)propane] (Wako Pure Chemical Industries Co., Ltd. product name; VA-061), 2,2'-azobis(2-methylpropionamidine) dihydrochloride (Wako Pure Chemical Industries Co., Ltd. Product name; V-50), 2,2'-azobis[2-methyl-N-(2-hydroxyethyl)propanamide) (Wako Pure Chemical Co., Ltd. product name; VA-086), Benzoyl benzoate (BPO), 2,2'-azobis(N-(2-carboxyethyl)-2-methylpropionamidine) n-hydrate (Wako Pure Chemical Industries, Ltd.); VA -057), 4,4'-azobis(4-cyanovaleric acid) (manufactured by Wako Pure Chemical Industries, Ltd. Name; VA-501), peroxodisulfate or tert-butyl hydroperoxide, etc., among which, in consideration of ion balance and solubility in water, 2,2'-azo is preferably used. Bis[2-methyl-N-(2-hydroxyethyl)propanamide), 2,2'-azobis(N-(2-carboxyethyl)-2-methylpropionamidine)-hydration , 4,4'-azobis(4-cyanovaleric acid), 2,2'-azobis[2-(2-imidazolidin-2-yl)propane) dihydrochloride, 2,2 '-Azobis[2-(2-imidazolidin-2-) Propane]disulfate dihydrate, 2,2'-azobis[2-(2-imidazolidin-2-yl)propane], 2,2'-azobis(2-methylpropionamidine) Any of dihydrochloride or peroxodisulfuric acid.

反應條件係藉由將反應容器在油浴等中加熱至50℃~200℃,施行1小時~48小時攪拌,而進行聚合反應並獲得本案之共聚物。反應環境較佳為氮環境。 The reaction conditions are carried out by heating the reaction vessel to 50 ° C to 200 ° C in an oil bath or the like, and stirring for 1 hour to 48 hours to obtain a copolymer of the present invention. The reaction environment is preferably a nitrogen environment.

作為反應順序,可將所有反應用物質全部置入室溫的反應溶媒中之後,加熱至上述溫度而使其進行聚合,亦可在預先加溫之溶媒中,每次少量地滴下反應用物質的混合物全部或一部分。 In the reaction sequence, all of the reaction materials may be placed in a reaction solvent at room temperature, and then heated to the above temperature to be polymerized, or the reaction material may be dropped in a small amount in a preheated solvent. All or part of the mixture.

本案共聚物的分子量只要是數千至數百萬左右即可,較佳為1,000~5,000,000。此外,無規共聚物、嵌段共聚物、接枝共聚物皆可,對用以製造該共聚物之共聚合反應本身並無特別限制,可使用利用自由基聚合或離子聚合或光聚合、大分子單體(macromer)、乳化聚合之聚合等公知的在溶液中進行合成之方法。此等係依目標用途,可單獨使用本發明之共聚物中之任一者,亦可將複數種共聚物進行混合,且改變其比率而使用。 The molecular weight of the copolymer of the present invention may be from several thousands to several millions, preferably from 1,000 to 5,000,000. Further, a random copolymer, a block copolymer, or a graft copolymer may be used, and the copolymerization reaction for producing the copolymer itself is not particularly limited, and it may be used by radical polymerization or ion polymerization or photopolymerization. A known method of synthesizing in a solution, such as a macromer or a polymerization of emulsion polymerization. These may be used singly or in combination with any of the copolymers of the present invention, or may be used by mixing a plurality of copolymers and changing the ratio thereof.

[實施例] [Examples]

以下,基於合成例、實施例,進一步詳細說明本發明,但本發明並不限定於此等合成例、實施例。 Hereinafter, the present invention will be described in more detail based on Synthesis Examples and Examples, but the present invention is not limited to the Synthesis Examples and Examples.

<合成例1~合成例6> <Synthesis Example 1 to Synthesis Example 6>

將丙烯酸3-磺酸基丙酯鉀鹽(KSPA;(式3-2)之Tb=H(氫原子)、Ua1=K(鉀原子)之化合物,Aldrich公司製)10.8g及丙烯酸2-(二甲基胺基)乙基甲酯(DMAEMA;(式3-4)之化合物,和光純藥工業(股)製)12.3mL各溶解於100mL的超純水中後,添加超純水,將各溶液定容至200mL。將2,2’-偶氮雙(N-(2-羧基乙基)-2-甲基丙脒)n-水合物(製品名;VA-057,和光純藥工業(股)製)0.304g溶解於12.3mL的超純水中。在200mL試驗管中,以表1之比例置入上述KSPA水溶液、DMAEMA水溶液、VA-057水溶液及超純水,經約60分鐘的利用氮通氣之氮置換後,於封入下,在70℃使其進行16小時聚合反應,獲得各共聚物1~共聚物6。反應終了後,將反應溶液封入至分劃分子量3,500的透析管(Specrta/Por(註冊商標)6,Dialysis Membrane)中,在超純水500mL中進行透析10日。此時,超純水係每12小時進行替換。透析後之濃度係在100℃進行16小時蒸發乾固而決定(表1)。共聚物之組成比(KSPA:DMAEMA)係將60μL的高分子水溶液於載玻片上以70℃、3小時作成乾燥膜,基於X射線光電子分光(XPS)測定由氮/硫元素比而決定(表1)。 The sulfonic acid group, propyl acrylate, 3-potassium salt (KSPA; (formula 3-2) of T b = H (hydrogen atom), U a1 = K (potassium atom) of the compound, Aldrich Corporation) and 10.8 g of acrylic acid 2 -(Dimethylamino)ethylmethyl ester (DMAEMA; compound of formula (3-4), and Wako Pure Chemical Industries, Ltd.) 12.3 mL each dissolved in 100 mL of ultrapure water, then added ultrapure water The solution was made up to 200 mL. 2,2'-Azobis(N-(2-carboxyethyl)-2-methylpropionamidine) n-hydrate (product name; VA-057, manufactured by Wako Pure Chemical Industries, Ltd.) 0.304 g Dissolved in 12.3 mL of ultrapure water. The above-mentioned KSPA aqueous solution, DMAEMA aqueous solution, VA-057 aqueous solution and ultrapure water were placed in a 200 mL test tube at a ratio of Table 1, and after nitrogen replacement with nitrogen for about 60 minutes, the mixture was sealed at 70 ° C for 70 minutes. This was subjected to a polymerization reaction for 16 hours to obtain each copolymer 1 to copolymer 6. After the completion of the reaction, the reaction solution was sealed in a dialysis tube (Specrta/Por (registered trademark) 6, Dialysis Membrane) having a molecular weight of 3,500, and dialyzed for 10 days in 500 mL of ultrapure water. At this time, the ultrapure water system was replaced every 12 hours. The concentration after dialysis was determined by evaporation and drying at 100 ° C for 16 hours (Table 1). The composition ratio of the copolymer (KSPA: DMAEMA) was prepared by drying 60 μL of the aqueous polymer solution on a glass slide at 70 ° C for 3 hours, and determined by X-ray photoelectron spectroscopy (XPS) from the nitrogen/sulfur element ratio (Table) 1).

<合成例7> <Synthesis Example 7>

將2.38g的KSPA、23.6μL的DMAEMA及17.9mg的VA-057溶於80mL的超純水中後,置入200mL的試驗管中,施行與上述合成例1~合成例6同樣的操作,獲得共聚物7。透析後之共聚物7的濃度為0.618質量%。所得共聚物7之組成為KSPA:DMAEMA=8.0:2.0。 2.38 g of KSPA, 23.6 μL of DMAEMA, and 17.9 mg of VA-057 were dissolved in 80 mL of ultrapure water, placed in a test tube of 200 mL, and subjected to the same operation as in Synthesis Example 1 to Synthesis Example 6 described above. Copolymer 7. The concentration of the copolymer 7 after dialysis was 0.618% by mass. The composition of the obtained copolymer 7 was KSPA: DMAEMA = 8.0: 2.0.

<合成例8> <Synthesis Example 8>

將0.165g的KSPA、2.39mL的DMAEMA及25.5mg的VA-057溶於80mL的超純水中後,置入200mL的試驗管中,施行與上述合成例1~合成例6同樣的操作,獲得共聚物8。透析後之共聚物8的濃度為0.344質量%。所得共聚物8之組成為KSPA:DMAEMA=0.9:9.1。 0.165 g of KSPA, 2.39 mL of DMAEMA, and 25.5 mg of VA-057 were dissolved in 80 mL of ultrapure water, placed in a test tube of 200 mL, and subjected to the same operation as in Synthesis Example 1 to Synthesis Example 6 described above. Copolymer 8. The concentration of the copolymer 8 after dialysis was 0.344% by mass. The composition of the obtained copolymer 8 was KSPA: DMAEMA = 0.9: 9.1.

(塗膜形成用組成物之調製) (Modulation of composition for coating film formation)

使共聚物1~共聚物8以成為0.05質量%之方式各溶 解於超純水或PBS(pH=7.4)中而製作塗膜形成用組成物1~8(溶媒:水溶液)、塗膜形成用組成物9~16(溶媒:PBS)。 The copolymer 1 to the copolymer 8 were each dissolved in a manner of 0.05% by mass. The coating film-forming compositions 1 to 8 (solvent: aqueous solution) and the coating film-forming composition 9 to 16 (solvent: PBS) were prepared by dissolving in ultrapure water or PBS (pH = 7.4).

<實施例1~實施例16> <Example 1 to Example 16>

使用上述組成物1~16,在玻璃基板上製作實施例1~16之塗膜。 The coating films of Examples 1 to 16 were produced on the glass substrate using the above compositions 1 to 16.

(1)使組成物接觸至玻璃基板表面。 (1) The composition is brought into contact with the surface of the glass substrate.

(2)利用超純水(實施例1~8)、或PBS(實施例9~16)洗淨3次 (2) Washing 3 times with ultrapure water (Examples 1 to 8) or PBS (Examples 9 to 16)

(3)風乾 (3) air drying

玻璃基板係依以下之方式進行製作。 The glass substrate was produced in the following manner.

[實施水蒸氣電漿處理之玻璃(SiOH表面)] [Performed glass treated with steam plasma (SiOH surface)]

對具有24孔直徑4mm的窗之高撥水性印刷載玻片(松浪硝子工業(股)製,TF2404(Non-Coat型))實施60秒水蒸氣電漿處理。試料表面係將未實施撥水處理之直徑4mm的玻璃表面作成SiOH表面。 A 60-second steam plasma treatment was carried out on a high water-repellent printing slide (manufactured by Matsuron Glass Industry Co., Ltd., TF2404 (Non-Coat type)) having a window of 24 mm in diameter and 4 mm. The surface of the sample was formed into a SiOH surface by a glass surface having a diameter of 4 mm which was not subjected to water repellent treatment.

[水液滴接觸角] [Water droplet contact angle]

水液滴的接觸角之測定係使用接觸角計(協和界面科學(股)製,型號:CA-D),藉由液適法而求出。 The contact angle of the water droplets was determined by a liquid-adapted method using a contact angle meter (manufactured by Kyowa Interface Science Co., Ltd., model: CA-D).

將測定實施例1~實施例16之玻璃基板的水接觸角之結果示於[表2]。 The results of measuring the water contact angles of the glass substrates of Examples 1 to 16 are shown in [Table 2].

測定值係以n=10施行之平均值。 The measured values are the average values performed with n=10.

與聚合物1~8之組成比無關地顯示接觸角13.0~45.0度,確認塗膜形成。 Regardless of the composition ratio of the polymers 1 to 8, the contact angle was 13.0 to 45.0 degrees, and the formation of the coating film was confirmed.

[蛋白質的附著特性] [Protein attachment properties]

蛋白質附著係使用螢光標定化牛血清白蛋白(FITC-BSA,pI(等電點)=4.7),對上述SiOH表面的附著量(螢光強度)進行相對於玻璃(比較例)而言之相對評估。將測定結果示於[表3]。 In the protein adhesion system, bovine serum albumin (FITC-BSA, pI (isoelectric point) = 4.7) was used, and the amount of adhesion (fluorescence intensity) on the surface of the SiOH was measured with respect to glass (comparative example). Relative evaluation. The measurement results are shown in [Table 3].

(條件) (condition)

FITC-BSA溶液:1.0mg/mL於PBS FITC-BSA solution: 1.0 mg/mL in PBS

培養條件:5% CO2,37℃ Culture conditions: 5% CO 2 , 37 ° C

接觸時間:6小時 Contact time: 6 hours

洗淨條件:利用15μL的PBS 2次,其後利用超純水2次 Washing conditions: use 15 μL of PBS twice, then use ultrapure water twice

[細胞黏著性評估] [Cell adhesion assessment]

藉由纖維芽細胞黏著特性施行評估。細胞係將V79細胞(源自中國倉鼠肺之纖維芽細胞)接種於上述玻璃基板,將於5% CO2環境下,於37℃培養48小時後之黏著數分成伸展細胞及未伸展細胞而進行評估。將結果示於[表4]。 Evaluation was performed by the fibrocyte adhesion characteristics. Cell line V79 cells (fiber bud cells derived from Chinese hamster lung) were inoculated on the above glass substrate, and the adhesion number was divided into stretched cells and unstretched cells after culturing at 37 ° C for 48 hours in a 5% CO 2 atmosphere. Evaluation. The results are shown in [Table 4].

[產業上之可利用性] [Industrial availability]

使用本案之離子複合物之塗膜係利用簡便的乾燥步驟而強固地固著於所有基板,該膜係具有活體物質附著抑制能。 The coating film using the ionic composite of the present invention is firmly fixed to all the substrates by a simple drying step, and the film has a living substance adhesion inhibiting ability.

可期待應用為對人工透析器、人工臟器、醫療器具等之活體物質附著抑制塗膜。 The application can be expected to be a coating film for inhibiting the adhesion of living substances such as artificial dialyzers, artificial organs, and medical instruments.

Claims (4)

一種塗膜,其係使包含共聚物及溶媒之塗膜形成用組成物接觸至基體後,予以乾燥而形成,該共聚物包含:含下述(式a)所示之1價有機基的重複單元、及含下述(式b)所示之1價有機基的重複單元; (式中,Ua1表示氫原子或鹼金屬原子,Ub1及Ub2各自獨立地表示氫原子或碳原子數1~5之直鏈或分枝烷基)。 A coating film comprising a composition for forming a coating film comprising a copolymer and a solvent, which is formed by contacting a substrate, and comprising: a repeat comprising a monovalent organic group represented by the following formula (a) a unit, and a repeating unit comprising a monovalent organic group represented by the following (formula b); (In the formula, U a1 represents a hydrogen atom or an alkali metal atom, and U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms). 如請求項1之塗膜,其中,上述基體係選自玻璃、含有金屬的化合物或含有半金屬的化合物、或樹脂。 The coating film of claim 1, wherein the base system is selected from the group consisting of glass, a metal-containing compound or a semimetal-containing compound, or a resin. 如請求項1或2之塗膜,其係具有活體物質的附著抑制能。 The coating film of claim 1 or 2 which has an adhesion inhibiting ability of a living substance. 如請求項1至3中任一項之塗膜,其中,上述共聚物包含選自下述(式a-1)及(式b-1)所組成之群組之至少1種重複單元; (式中,Ta、Tb、Ub1及Ub2各自獨立地表示氫原子或碳原子數1~5之直鏈或分枝烷基,Ua1表示氫原子或鹼金屬原子,Qa及Qb各自獨立地表示單鍵、酯鍵(-C(=O)-O-或-O-C(=O)-)或醯胺鍵(-NHC(=O)-或-C(=O)NH-),Ra及Rb各自獨立地表示單鍵或可經鹵素原子取代之碳原子數1~5之直鏈或分枝伸烷基)。 The coating film according to any one of claims 1 to 3, wherein the copolymer comprises at least one repeating unit selected from the group consisting of the following (formulae-1) and (formula b-1); (wherein, T a , T b , U b1 and U b2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, and U a1 represents a hydrogen atom or an alkali metal atom, Q a and Q b each independently represents a single bond, an ester bond (-C(=O)-O- or -OC(=O)-) or a guanamine bond (-NHC(=O)- or -C(=O)NH -), R a and R b each independently represent a single bond or a straight or branched alkyl group having 1 to 5 carbon atoms which may be substituted by a halogen atom.
TW104106778A 2014-03-03 2015-03-03 Ion complex material having function for preventing adherence to biological material TW201602260A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014040939A JP2017078090A (en) 2014-03-03 2014-03-03 Ion complex material having ability to inhibit the attachment of biomaterial

Publications (1)

Publication Number Publication Date
TW201602260A true TW201602260A (en) 2016-01-16

Family

ID=54055267

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104106778A TW201602260A (en) 2014-03-03 2015-03-03 Ion complex material having function for preventing adherence to biological material

Country Status (3)

Country Link
JP (1) JP2017078090A (en)
TW (1) TW201602260A (en)
WO (1) WO2015133461A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021256553A1 (en) * 2020-06-19 2021-12-23 日産化学株式会社 Composition for coating film formation including phosphate-group-containing polymer
CN112607733B (en) * 2020-12-16 2023-11-21 合肥霏润新能源技术有限公司 Preparation method and application of polymer-based nitrogen and phosphorus doped graphitized porous carbon

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5230031B2 (en) * 1973-02-09 1977-08-05
JPS6148376A (en) * 1984-08-13 1986-03-10 旭化成株式会社 Improved blood purification membrane and its production
JPH02215871A (en) * 1989-02-17 1990-08-28 Sumitomo Light Metal Ind Ltd Hydrophilic coating agent, aluminum or aluminum-alloy plate for fin and heat exchanger
JPH02219873A (en) * 1989-02-21 1990-09-03 Sumitomo Light Metal Ind Ltd Hydrophilic coating agent, aluminum or aluminum alloy sheet for fin and heat exchanger
JPH02219876A (en) * 1989-02-21 1990-09-03 Sumitomo Light Metal Ind Ltd Hydrophilic coating agent, aluminum or aluminum alloy sheet for fin and heat exchanger
JPH02219879A (en) * 1989-02-21 1990-09-03 Sumitomo Light Metal Ind Ltd Hydrophilic coating agent, aluminum or aluminum alloy sheet for fin and heat exchanger
JP2610336B2 (en) * 1989-02-22 1997-05-14 東洋インキ製造株式会社 Curable composition for coating and recording medium
JPH06172562A (en) * 1992-11-25 1994-06-21 Diafoil Co Ltd Laminated polyester film
JPH0867855A (en) * 1994-06-22 1996-03-12 Sekisui Chem Co Ltd Binder for magnetic recording material and magnetic recording material
JPH0867854A (en) * 1994-06-22 1996-03-12 Sekisui Chem Co Ltd Binder for magnetic recording material and magnetic recording material
JPH08232078A (en) * 1994-12-07 1996-09-10 Nippon Parkerizing Co Ltd Hydrophilic aqueous processing agent of aluminum-containing metallic material and hydrophilic treatment
US5539073A (en) * 1995-04-12 1996-07-23 Eastman Chemical Company Waterborne polymers having pendant allyl groups
JP3437682B2 (en) * 1995-06-22 2003-08-18 三菱化学ポリエステルフィルム株式会社 Laminated polyester film
JPH09296121A (en) * 1996-05-02 1997-11-18 Nippon Parkerizing Co Ltd Aqueous agent for surface hydrophilization treatment of metallic material and surface-treating method
JP4242557B2 (en) * 1997-08-15 2009-03-25 イーストマン ケミカル カンパニー Use of surfactants as plasticizers to reduce volatile organic compounds in aqueous polymer coating compositions.
JP2003049121A (en) * 2001-08-09 2003-02-21 Hitachi Chem Co Ltd Antifogging coating, antifogging molded article, antifogging sheet and antifogging film coated with the same
JP5467715B2 (en) * 2007-09-03 2014-04-09 株式会社Uacj Hydrophilic lubricating paint for aluminum and article to be coated using the same

Also Published As

Publication number Publication date
WO2015133461A1 (en) 2015-09-11
JP2017078090A (en) 2017-04-27

Similar Documents

Publication Publication Date Title
JP7131585B2 (en) ION COMPLEX MATERIAL AND METHOD FOR MANUFACTURING THE SAME
JP6835114B2 (en) Ion complex material having the ability to suppress the adhesion of biological substances and its manufacturing method
JP6911852B2 (en) Cryopreservation container
WO2018016463A1 (en) Coating film having thin film step coverage and structural substrate equipped with said film
EP3719113A1 (en) Cell culture container capable of long-term culture, and method for manufacturing same
TW201602260A (en) Ion complex material having function for preventing adherence to biological material
JP6417818B2 (en) Sterilized coating membrane
WO2017006850A1 (en) Ion complex material having ability to inhibit adhesion of biological materials, and method for producing same
TW202146484A (en) Adhesion inhibitor for biomaterials
EP3925990A1 (en) Method for producing polymer compatible with biomaterials
TW202307021A (en) Composition for forming coating film, coating film and cell culture container